MYBIOMETRY

Investments
Written By NYA

myBiometry is a platform that remotely monitors and manages patients with asthma using software and biomarker data generated from proprietary sensors.  New York Angels Members invested in the company for the first time due to its proprietary design that can help stop asthma attacks before they happen by measuring biomarkers of airway inflammation, specifically fractional exhaled nitric oxide in a patient’s breath. Hugh Cullman and Vijay Aggarwal helped finalize NYA Members' investment. 

NYA
Previous

JOSHUA POWE ‒ NYA MEMBER SPOTLIGHT
Next

NYA FOUNDER SPOTLIGHT ‒ STEPHEN KINES, GOLDILOCK COO & CO-FOUNDER